SCHEMBL30426262

SCHEMBL30426262

CCCCCCCCC=CCC(CCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.63
PRKCE Q02156 1/20 0.63
PRKCQ Q04759 1/20 0.63
PRKCD Q05655 1/20 0.63
MAPT P10636 2/20 0.59
ALDH1A1 P00352 2/20 0.59
FAAH O00519 1/20 0.59
HPGD P15428 1/20 0.59
CNR1 P21554 1/20 0.59
CNR2 P34972 1/20 0.59
SLC6A5 Q9Y345 1/20 0.57
LPAR1 Q92633 1/20 0.56
FFAR1 O14842 1/20 0.56
FFAR4 Q5NUL3 1/20 0.56
MAPK1 P28482 1/20 0.55
DAGLA Q9Y4D2 2/20 0.54
S1PR1 P21453 1/20 0.54
LMNA P02545 1/20 0.53
DGKA P23743 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29421612 1.00 PRKCA (0.63) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL30425747 1.00 PRKCA (0.63) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL30426114 1.00 PRKCA (0.63) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL29421627 0.96 ALDH1A1 (0.67) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL24792639 0.95 PRKCA (0.57) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL24980149 0.95 FFAR1 (0.65) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL22469993 0.95 FFAR1 (0.65) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL24791986 0.95 FFAR1 (0.65) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL22274247 0.95 FFAR1 (0.61) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL22469994 0.95 FFAR1 (0.65) PRKCAPRKCEPRKCQPRKCDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025123147-A1 TOLERIZING IMMUNOMODULATORY COMBINATION INTEGRATED NANOTHERAPEUTICS INC. (CA) 2025-06-19 WO disclosed
EP-4398930-A1 IMMUNOMODULATORY COMBINATIONS OF ANTIGEN AND DRUG-LIPID CONJUGATE Integrated Nanotherapeutics Inc. (CA) 2024-07-17 EP disclosed
WO-2023035068-A1 IMMUNOMODULATORY COMBINATIONS OF ANTIGEN AND DRUG-LIPID CONJUGATE INTEGRATED NANOTHERAPEUTICS INC. (CA) 2023-03-16 WO disclosed